FOXO (foxotechnologies.com) מחיר חזוי לרווח

FOXO Technologies develops AI services for DNA biomarker analysis, leveraging cloud computing power while maintaining proprietary algorithms. The company's forward P/E ratio reflects market valuation dynamics, with the metric currently standing at 0.00. This synergy of technology and insurance enables more precise determination of longevity risks, transforming the analytical system into a fundamental industry standard.

For FOXO Technologies, which is shifting its business strategy due to a capital shortage, the company's forward P/E valuation reflects market expectations regarding the implementation of AI platforms. This ratio is calculated as the current share price divided by projected earnings, allowing investors to determine the premium paid for future income amid high uncertainty over commercial prospects and delisting risks.